Clincosm LogoSign in Get a demo

stage iv skin melanoma

Showing 1 - 24 of 24
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Recurrent Melanoma, Stage IIIB Skin Melanoma, Stage IIIC Skin Melanoma Trial in Buffalo (Recombinant Human Hsp110-gp100

Terminated
  • Recurrent Melanoma
  • +3 more
  • Recombinant Human Hsp110-gp100 Chaperone Complex Vaccine
  • Laboratory Biomarker Analysis
  • Buffalo, New York
    Roswell Park Cancer Institute
Jul 20, 2022

Acute Myeloid Leukemia, Brain Glioblastoma, Estrogen Receptor Negative Trial in Fullerton (Best Practice, Laboratory Biomarker

Active, not recruiting
  • Acute Myeloid Leukemia
  • +66 more
  • Best Practice
  • +3 more
  • Fullerton, California
    Virginia K Crosson Cancer Center
Jan 31, 2022

Metastatic Malignant Tumor in the Brain, Metastatic Malignant Tumor in the Spine, Stage IV Skin Melanoma Trial in Baltimore

Completed
  • Metastatic Malignant Neoplasm in the Brain
  • +2 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Baltimore, Maryland
    Johns Hopkins University/Sidney Kimmel Cancer Center
Nov 29, 2021

Metastatic Melanoma, Stage III Mucosal Melanoma of the Head and Neck, Stage IIIA Skin Melanoma Trial in New Brunswick

Active, not recruiting
  • Metastatic Melanoma
  • +8 more
  • Aldesleukin
  • +2 more
  • New Brunswick, New Jersey
    Rutgers Cancer Institute of New Jersey
Sep 20, 2021

Malignant Female Reproductive System Tumor, Malignant Hepatobiliary Tumor, Partner Trial in New Brunswick (Cognitive Behavior

Completed
  • Malignant Female Reproductive System Neoplasm
  • +38 more
  • Cognitive Behavior Therapy
  • +3 more
  • New Brunswick, New Jersey
    Rutgers Cancer Institute of New Jersey
Apr 7, 2021

Recurrent Melanoma, Stage IA Skin Melanoma, Stage IB Skin Melanoma Trial in Buffalo (procedure, drug, other)

Completed
Has Results
  • Recurrent Melanoma
  • +9 more
  • Diagnostic Microscopy
  • +3 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Jul 24, 2020

Recurrent Melanoma, Stage IV Skin Melanoma Trial in Seattle (biological, other, radiation)

Terminated
Has Results
  • Recurrent Melanoma
  • Stage IV Skin Melanoma
  • Ipilimumab
  • +3 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jan 31, 2020

Stage IIA Skin Melanoma, Stage IIB Skin Melanoma, Stage IIC Skin Melanoma Trial in Rochester (biological, drug, other)

Completed
  • Stage IIA Skin Melanoma
  • +6 more
  • MART-1 Antigen
  • +2 more
  • Rochester, Minnesota
    Mayo Clinic
Jan 13, 2020

Recurrent Melanoma, Stage IV Skin Melanoma Trial in New York (Cisplatin, Gamma-Secretase Inhibitor RO4929097, Laboratory

Completed
Has Results
  • Recurrent Melanoma
  • Stage IV Skin Melanoma
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
Oct 24, 2019

Stage IV Skin Melanoma Trial in Rochester (other, procedure, biological)

Completed
  • Stage IV Skin Melanoma
  • Laboratory Biomarker Analysis
  • +2 more
  • Rochester, Minnesota
    Mayo Clinic
Aug 1, 2019

Stage IIIC Skin Melanoma, Stage IV Skin Melanoma Trial in Jette (nivolumab, ipilimumab)

Completed
  • Stage IIIC Skin Melanoma
  • Stage IV Skin Melanoma
  • Jette, Brabant, Belgium
    UZ Brussel
Jan 22, 2019

Stage IV Skin Melanoma, Eye; Melanoma Trial in Amsterdam (TCR transduced T-cells, Biopsy, Blood taking)

Unknown status
  • Stage IV Skin Melanoma
  • Eye; Melanoma
  • TCR transduced T-cells
  • +2 more
  • Amsterdam, NH, Netherlands
    Antoni van Leeuwenhoek ziekenhuis
Oct 31, 2018

Stage IA Skin Melanoma, Stage IB Skin Melanoma, Stage IIA Skin Melanoma Trial in Columbus (recombinant interferon alfa-2b,

Completed
Has Results
  • Stage IA Skin Melanoma
  • +8 more
  • recombinant interferon alfa-2b
  • laboratory biomarker analysis
  • Columbus, Ohio
    Ohio State University Medical Center
Oct 31, 2018

Stage IIIA Skin Melanoma, Stage IIIB Skin Melanoma, Stage IIIC Skin Melanoma Trial (drug, other, biological)

Withdrawn
  • Stage IIIA Skin Melanoma
  • +3 more
  • Imatinib Mesylate
  • +2 more
  • (no location specified)
Apr 3, 2018

Recurrent Melanoma, Stage III Skin Melanoma, Stage IV Skin Melanoma Trial in San Antonio (biological, other, drug)

Completed
Has Results
  • Recurrent Melanoma
  • +2 more
  • Bevacizumab
  • +3 more
  • San Antonio, Texas
    Cancer Therapy and Research Center at The UT Health Science Cent
Oct 19, 2017

Recurrent Melanoma, Stage IIIA Skin Melanoma, Stage IIIB Skin Melanoma Trial in United States (biological, drug, other)

Completed
Has Results
  • Recurrent Melanoma
  • +4 more
  • Aldesleukin
  • +5 more
  • Birmingham, Alabama
  • +18 more
Nov 16, 2017

Recurrent Melanoma, Stage IIIB Skin Melanoma, Stage IIIC Skin Melanoma Trial in Philadelphia, Charlottesville (biological,

Completed
Has Results
  • Recurrent Melanoma
  • +3 more
  • Bevacizumab
  • +3 more
  • Philadelphia, Pennsylvania
  • +1 more
May 5, 2017

Recurrent Melanoma, Stage IV Skin Melanoma Trial in Chicago (NA17.A2 Peptide Vaccine, Recombinant MAGE-3.1 Antigen, Recombinant

Terminated
Has Results
  • Recurrent Melanoma
  • Stage IV Skin Melanoma
  • NA17.A2 Peptide Vaccine
  • +4 more
  • Chicago, Illinois
    University of Chicago Comprehensive Cancer Center
Aug 31, 2016

Anaplastic Astrocytoma, Anaplastic Oligoastrocytoma, Anaplastic Oligodendroglioma Trial in Buffalo (biological, other, drug)

Completed
  • Anaplastic Astrocytoma
  • +64 more
  • DEC-205/NY-ESO-1 Fusion Protein CDX-1401
  • +3 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Oct 3, 2016

Recurrent Melanoma, Stage IV Skin Melanoma Trial in Cincinnati, Columbus (Recombinant Interferon Alfa, Bevacizumab)

Completed
Has Results
  • Recurrent Melanoma
  • Stage IV Skin Melanoma
  • Recombinant Interferon Alfa
  • Bevacizumab
  • Cincinnati, Ohio
  • +1 more
Feb 18, 2016

Mucosal Melanoma, Recurrent Melanoma, Stage IIIA Skin Melanoma Trial in Australia, United States (Carboplatin, Laboratory

Completed
Has Results
  • Mucosal Melanoma
  • +5 more
  • Birmingham, Alabama
  • +218 more
Sep 28, 2015

Recurrent Melanoma, Stage III Skin Melanoma, Stage IV Skin Melanoma Trial in New York (Laboratory Biomarker Analysis,

Completed
Has Results
  • Recurrent Melanoma
  • +2 more
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
Jul 16, 2015

BRAFV600 Serum and Plasma Determination in BRAFV600 Metastatic

Completed
  • Stage IV Skin Melanoma
    • Madrid, Badajoz, Spain
    • +12 more
    May 4, 2015

    Recurrent Melanoma, Stage IA Skin Melanoma, Stage IB Skin Melanoma Trial in Portland (gp100:209-217(210M) Peptide Vaccine, HPV

    Completed
    • Recurrent Melanoma
    • +9 more
    • gp100:209-217(210M) Peptide Vaccine
    • +2 more
    • Portland, Oregon
      Providence Portland Medical Center
    Jan 23, 2015